AVI BioPharma, Inc. · Bothell, WA United States (NASDAQ: AVII)
| 3450 Monte Villa Pkwy., Ste. 101 | Phone: 425-354-5038 |
| Bothell, WA | |
| 98021 | |
| United States | 
Map This Company |
AVI BioPharma, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
AVI BioPharma has a sixth sense about antisense. A developer of biopharmaceutical compounds, the company's investigational therapies are based on its antisense drug technology, which can halt disease processes at the genetic level. The drug developer is working on drugs that could potentially be used in the treatment of a wide range of conditions, including genetic and infectious diseases. AVI BioPharma's had research and development programs for targets including muscular dystrophy, hepatitis C, pandemic influenza, the Ebola virus, and Dengue fever.
AVI BioPharma, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: AVII Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 98 |
Executives
20 executives listed for AVI BioPharma, Inc.'s Bothell, WA location.
| President, CEO, and Director | Christopher Garabedian | |
|---|---|---|
| SVP and Chief Scientific Officer | Peter Linsley | |
| SVP and Chief Medical Officer | Ed Kaye |